MarketInOut Stock Screener Log In | Sign Up

Viking Therapeutics Inc

XETRA • Healthcare • Biotechnology • Quote as of 10/30/2026
Viking Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeXETRA
Market Capitalization2,842.14 mln
Float123 mln
Earnings Date10/28/2026

Piotroski F-Score

1 / 9
Very weak

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.01
Debt-free

ROE

-87.45
Deeply negative

ROA

-78.34
Deeply negative

Business Description

Viking Therapeutics is a San Diego-based drug development company focused on creating new treatments for hormonal and metabolic conditions. The company has several medications in clinical testing, targeting diseases such as fatty liver disease, muscle loss following hip fracture surgery, and a rare genetic neurological disorder. Founded in 2012, Viking Therapeutics has not yet brought a product to market but continues to advance its pipeline of experimental drugs through various stages of human trials.

Key Fundamentals

EPS-4.08
ROE-87.45
ROIC-38,638
ROA-78.34
EBITDA, mln-458
EV / EBITDA-4.96
EV / EBIT-4.96

Quote Details

Last 24.25
Change -0.1 (-0.41%)
Open 23.90
Volume 91
Turnover 2,206.75
Average Volume 606.29

Financial Ratios

Current Ratio4.72
Price / Book7.11
Price / Tangible Book7.11
Debt / Equity0.01

Financial Strength

Piotroski F-Score 1 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.99% 99 / 100   
1 Month -12.45% 7 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog